Unknown

Dataset Information

0

ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression.


ABSTRACT: Metastatic cancer is extremely difficult to treat, and the presence of metastases greatly reduces a cancer patient's likelihood of long-term survival. The ZEB1 transcriptional repressor promotes metastasis through downregulation of microRNAs (miRs) that are strong inducers of epithelial differentiation and inhibitors of stem cell factors. Given that each miR can target multiple genes with diverse functions, we posited that the prometastatic network controlled by ZEB1 extends beyond these processes. We tested this hypothesis using a mouse model of human lung adenocarcinoma metastasis driven by ZEB1, human lung carcinoma cells, and human breast carcinoma cells. Transcriptional profiling studies revealed that ZEB1 controls the expression of numerous oncogenic and tumor-suppressive miRs, including miR-34a. Ectopic expression of miR-34a decreased tumor cell invasion and metastasis, inhibited the formation of promigratory cytoskeletal structures, suppressed activation of the RHO GTPase family, and regulated a gene expression signature enriched in cytoskeletal functions and predictive of outcome in human lung adenocarcinomas. We identified several miR-34a target genes, including Arhgap1, which encodes a RHO GTPase activating protein that was required for tumor cell invasion. These findings demonstrate that ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression and provide a compelling rationale to develop miR-34a as a therapeutic agent in lung cancer patients.

SUBMITTER: Ahn YH 

PROVIDER: S-EPMC3428095 | biostudies-literature | 2012 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression.

Ahn Young-Ho YH   Gibbons Don L DL   Chakravarti Deepavali D   Creighton Chad J CJ   Rizvi Zain H ZH   Adams Henry P HP   Pertsemlidis Alexander A   Gregory Philip A PA   Wright Josephine A JA   Goodall Gregory J GJ   Flores Elsa R ER   Kurie Jonathan M JM  

The Journal of clinical investigation 20120801 9


Metastatic cancer is extremely difficult to treat, and the presence of metastases greatly reduces a cancer patient's likelihood of long-term survival. The ZEB1 transcriptional repressor promotes metastasis through downregulation of microRNAs (miRs) that are strong inducers of epithelial differentiation and inhibitors of stem cell factors. Given that each miR can target multiple genes with diverse functions, we posited that the prometastatic network controlled by ZEB1 extends beyond these process  ...[more]

Similar Datasets

| S-EPMC6327052 | biostudies-literature
| S-EPMC4714815 | biostudies-literature
| S-EPMC7395373 | biostudies-literature
| S-EPMC2706787 | biostudies-literature
| S-EPMC3664824 | biostudies-other
| S-EPMC5873879 | biostudies-literature
| S-EPMC4442128 | biostudies-literature
| S-EPMC4694975 | biostudies-literature
| S-EPMC6085392 | biostudies-literature
| S-EPMC4227432 | biostudies-literature